MiMedx Stock Rebound Doesn't Sink Shareholder Suit

A Georgia federal judge is refusing to dismiss a shareholder class action against MiMedx Group Inc. over statements that its scar-minimizing injectables weren't subject to normal FDA regulation, saying Wednesday that...

Already a subscriber? Click here to view full article